Viewing Study NCT00286793


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-06-14 @ 2:23 PM
Study NCT ID: NCT00286793
Status: COMPLETED
Last Update Posted: 2011-06-29
First Post: 2006-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
Sponsor: Ascenta Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None at-101 View
None at101 View
None cancer View
None hormone refractory View
None prostate View
None docetaxel View
None prednisone View